BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37253610)

  • 1. Prognostic Significance of Early Declines in Pulmonary Function After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yadav H; Torghabeh MH; Hogan WJ; Limper AH
    Respir Care; 2023 Oct; 68(10):1406-1416. PubMed ID: 37253610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Lower Respiratory Tract Infections and Community-Acquired Respiratory Viruses in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: A Retrospective Cohort Study.
    Epstein DJ; Liang EC; Sharifi H; Lai YK; Arai S; Graber-Naidich A; Sundaram V; Nelson J; Hsu JL
    Transplant Cell Ther; 2022 Oct; 28(10):705.e1-705.e10. PubMed ID: 35872303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yoon JS; Chun YH; Lee JW; Chung NG; Cho B
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):e462-7. PubMed ID: 26334431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of pulmonary function test before transplantation for chronic pulmonary graft-versus-host-disease after allogeneic hematopoietic stem cell transplantation.
    Yang L; Cheng J; Li F; Qian R; Zhang X; Jin S; He X; Xu T; Hu X; Ma X; Chen J; Zhu Y; Chen F
    BMC Pulm Med; 2022 Dec; 22(1):473. PubMed ID: 36510158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
    Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
    Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS
    Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
    Bergeron A; Chevret S; Granata A; Chevallier P; Vincent L; Huynh A; Tabrizi R; Labussiere-Wallet H; Bernard M; Chantepie S; Bay JO; Thiebaut-Bertrand A; Thepot S; Contentin N; Fornecker LM; Maillard N; Risso K; Berceanu A; Blaise D; Peffault de La Tour R; Chien JW; Coiteux V; Socié G;
    JAMA; 2017 Aug; 318(6):557-566. PubMed ID: 28787506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic cell transplantation.
    Monagel DA; Guilcher GMT; Nettel-Aguirre A; Bendiak GN
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29927. PubMed ID: 35927947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
    Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome.
    Piñana JL; Martino R; Barba P; Bellido-Casado J; Valcárcel D; Sureda A; Briones J; Brunet S; Rodriguez-Arias JM; Casan P; Sierra J
    Am J Hematol; 2012 Jan; 87(1):9-14. PubMed ID: 22031451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
    Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
    Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation.
    Sheshadri A; Sacks NC; Healey BE; Raza S; Boerner G; Huang HJ
    Clin Ther; 2022 May; 44(5):755-765.e6. PubMed ID: 35513911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable pulmonary function after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single center experience.
    Paviglianiti A; Sestili S; Bianchessi A; Memoli M; Dulery R; Banet A; Van De Wyngaert Z; Belhocine R; Ledraa T; Malard F; Mohty M; Brissot E
    Leuk Lymphoma; 2022 Feb; 63(2):443-449. PubMed ID: 34587856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Body Lung Function Test-Derived Outcome Predictors in Allogenic Stem Cell Transplantation.
    Scheidl S; Zinke-Cerwenka W; Flick H; Gaal S; Avian A; Greinix H; Olschewski H
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):129-136. PubMed ID: 30064013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung hyperinflation quantitated by chest CT in children with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation.
    Moutafidis D; Gavra M; Golfinopoulos S; Oikonomopoulou C; Kitra V; Woods JC; Kaditis AG
    Clin Imaging; 2021 Jul; 75():97-104. PubMed ID: 33515927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function changes in long-term survivors of chronic myelogenous leukemia after allogeneic bone marrow transplantation: a Taiwan experience.
    Chiou TJ; Tung SL; Wang WS; Tzeng WF; Yen CC; Fan FS; Liu JH; Chen PM
    Cancer Invest; 2002; 20(7-8):880-8. PubMed ID: 12449718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
    Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Gazourian L; Rogers AJ; Ibanga R; Weinhouse GL; Pinto-Plata V; Ritz J; Soiffer RJ; Antin JH; Washko GR; Baron RM; Ho VT
    Am J Hematol; 2014 Apr; 89(4):404-9. PubMed ID: 24375545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Jung S; Yoon HM; Yoon J; Park M; Rhee ES; Kim H; Koh KN; Lee JS; Im HJ; Yu J
    Pediatr Pulmonol; 2021 Oct; 56(10):3332-3341. PubMed ID: 34357700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.
    Yoshihara S; Tateishi U; Ando T; Kunitoh H; Suyama H; Onishi Y; Tanosaki R; Mineishi S
    Bone Marrow Transplant; 2005 Jun; 35(12):1195-200. PubMed ID: 15852024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.